BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $810 to $826.
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $810 to $826.